Claims
- 1. A racemic mixture or optically active antipode of a compound of the formula ##STR8## wherein R.sub.1 is fluorine, chlorine, bromine, iodine or cyano,
- R.sub.2 is trifluoromethyl, nitro or cyano, and
- R.sub.3 is alkyl of 3 to 5 carbon atoms, hydroxy(alkyl of 3 to 5 carbon atoms), cycloalkyl of 3 to 5 carbon atoms, 1-(3,4-methylenedioxy-phenyl)-2-propyl or 1-(p-hydroxy-phenyl)-2-propyl,
- or a non-toxic, pharmacologically acceptable acid addition salt thereof.
- 2. A compound of claim 1, which is 1-(4'-amino-3'-chloro-5'-trifluoromethyl-phenyl)-2-tert.butylamino-ethanol or a non-toxic, pharmacologically acceptable acid addition salt thereof.
- 3. A compound of claim 1, which is 1-(4'-amino-3'-chloro-5'-trifluoromethyl-phenyl)-2-cyclobutylamino-ethanol or a non-toxic, pharmacologically acceptable acid addition salt thereof.
- 4. A compound of claim 1, which is 1-(4'-amino-3'-chloro-5'-cyano-phenyl)-2-tert.butylamino-ethanol or a nontoxic, pharmacologically acceptable acid addition salt thereof.
- 5. A compound of claim 1, which is 1-(4'-amino-3'-bromo-5'-cyano-phenyl)-2-tert.butylamino-ethanol or a nontoxic, pharmacologically acceptable acid addition salt thereof.
- 6. A pharmaceutical dosage unit composition consisting essentially of an inert pharmaceutical carrier and an effective bronchospasmolytic amount of a compound of claim 1.
- 7. The method of antagonizing bronchospasms in a warm-blooded animal in need of such treatment, which comprises perorally, parenterally or rectally administering to said animal a compound of claim 1.
Priority Claims (3)
Number |
Date |
Country |
Kind |
2261914 |
Dec 1972 |
DEX |
|
2345442 |
Sep 1973 |
DEX |
|
2351281 |
Oct 1973 |
DEX |
|
Parent Case Info
This is a continuation-in-part of copending application Ser. No. 426,949 filed Dec. 13, 1973, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
3536712 |
Keck et al. |
Oct 1970 |
|
3574211 |
Keck et al. |
Apr 1971 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
426949 |
Dec 1973 |
|